Patents by Inventor Diego Centonze

Diego Centonze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS
    Publication number: 20160310481
    Abstract: This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: March 23, 2016
    Publication date: October 27, 2016
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Gianvito Martino, Diego Centonze
  • Laquinimod for treatment of GABA mediated disorders
    Patent number: 9161936
    Abstract: This invention provides a method of treating a subject suffering from a GABA related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: October 20, 2015
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze
  • LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS
    Publication number: 20140045887
    Abstract: This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze
  • LAQUINIMOD FOR TREATMENT OF GABA MEDIATED DISORDERS
    Publication number: 20140045886
    Abstract: This invention provides a method of treating a subject suffering from a GABA related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze